Co může přinést studium oligomerizace proteinů v procesu onkogeneze?
[What Can Study of Oligomerization of Proteins in the Process of Oncogenesis Bring Us?]
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
26374152
DOI
10.14735/amko20152s6
PII: 55661
- MeSH
- Mass Spectrometry MeSH
- Carcinogenesis * MeSH
- Humans MeSH
- Protein Multimerization * MeSH
- Tumor Suppressor Protein p53 physiology MeSH
- Drug Design MeSH
- Deuterium Exchange Measurement MeSH
- Check Tag
- Humans MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Tumor Suppressor Protein p53 MeSH
Many cellular proteins form oligomers. The equilibrium between monomeric and oligomeric states of these proteins is important for the regulation of protein activity. Modulation of the oligomerization equilibrium could be an interesting approach in the development of new therapeutic agents. This review summarizes information about protein oligomerization and modulation of this process, demonstrating the role of oligomerization in oncogenesis by tumor suppressor protein p53, which forms tetrameric structure. Today, many studies focus on finding compounds that stabilize its tetramers. Among the methods for studying oligomerization, we present hydrogen/ deuterium exchange method coupled with mass spectrometry which is suitable for the detection of protein-protein interaction and analysis of oligomerization dynamics.
References provided by Crossref.org